Buscar

Mostrando ítems 1-10 de 220

Regulation of mitochondrial function as a promising target in platelet activation-related diseases

Fuentes, Eduardo; Araya Maturana, Ramiro; Urra, Félix A. (Elsevier Inc., 2019)

© 2019 Elsevier Inc.Platelets are anucleated cell elements produced by fragmentation of the cytoplasm of megakaryocytes and have a unique metabolic phenotype compared with circulating leukocytes, exhibiting a high coupling ...

Human platelet interaction with E-coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4

Autor desconocido (2017)

Platelets have a major role in clotting activation and contribute to the innate immune response during systemic infections. Human platelets contain tissue factor (TF) and express functional Toll-like receptor 4 (TLR4). ...

Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line zr-75-1

Autor desconocido (ISSUED FOR THE ENDOCRINE SOCIETY BY THE WILLIAMS & WILKINS CO, 2005)

Circulating platelet-derived microparticles in systemic lupus erythematosus - association with increased thrombin generation and procoagulant state

Autor desconocido (SCHATTAUER, 2006)

Fasudil prevents over expression of procoagulant, proinflammatory and profibrotic genes at the arterial wall in hypertensive rats

Autor desconocido

Inhibición del factor tisular por lipoproteínas de baja densidadLow-density lipoproteins (LDL) are circulating inhibitors of the pro-coagulant activity of tissue factor

Scoccia, Adriana E.; Molinuevo, María Silvina (2006)

Interaction of human platelets with strains of E. coli, induces platelet tissue factor-dependent procoagulant activity, thrombin generation in platelet-rich plasma and enhanced adhesion to endothelial

Autor desconocido (2015)

Referencia

Enhanced Platelet Tissue Factor-Dependent Procoagulant Activity In Hypercholesterolemia And In Pregnancy Dyslipidemia: Inhibition By Statins, Hdl-Cholesterol And Tissue Factor Pathway Inhibitor.

Pontificia Universidad Católica de Chile (2018)

Fasudil prevents over expression of procoagulant, proinflammatory and profibrotic genes at the arterial wall in hypertensive ratsRevista Chilena de Cardiología

Rivera, P.; Tichauer, J.; Lavandero, S.; Ocaranza, M. P.; Jalil, J. (2020)

Human platelet interaction with E-coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4

Matus, V.; Valenzuela, J.; Hidalgo, P.; Pozo, L.; Panes Becerra, Olga Teresa; Wozniak Banchero, Aniela; Mezzano, Diego; Pereira Garcés, Jaime Ignacio; Sáez, Claudia G. (2017)

1
2
3
4
. . .
22

Buscar

Filtros

Regulation of mitochondrial function as a promising target in platelet activation-related diseases

Human platelet interaction with E-coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4

Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line zr-75-1

Circulating platelet-derived microparticles in systemic lupus erythematosus - association with increased thrombin generation and procoagulant state

Fasudil prevents over expression of procoagulant, proinflammatory and profibrotic genes at the arterial wall in hypertensive rats

Inhibición del factor tisular por lipoproteínas de baja densidadLow-density lipoproteins (LDL) are circulating inhibitors of the pro-coagulant activity of tissue factor

Interaction of human platelets with strains of E. coli, induces platelet tissue factor-dependent procoagulant activity, thrombin generation in platelet-rich plasma and enhanced adhesion to endothelial

Enhanced Platelet Tissue Factor-Dependent Procoagulant Activity In Hypercholesterolemia And In Pregnancy Dyslipidemia: Inhibition By Statins, Hdl-Cholesterol And Tissue Factor Pathway Inhibitor.

Fasudil prevents over expression of procoagulant, proinflammatory and profibrotic genes at the arterial wall in hypertensive ratsRevista Chilena de Cardiología

Human platelet interaction with E-coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4